dehydroepiandrosterone sulfate has been researched along with formestane in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deckers, GH; Geelen, JA; Kloosterboer, HJ; Loozen, HJ; Tax, LJ; van der Wardt, JT | 1 |
| Choi, L; Haning, RV; Kiggens, AJ; Kuzma, DL; Summerville, JW | 2 |
3 other study(ies) available for dehydroepiandrosterone sulfate and formestane
| Article | Year |
|---|---|
Selection of 19-(ethyldithio)-androst-4-ene-3,17-dione (ORG 30958): a potent aromatase inhibitor in vivo.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dogs; Estradiol; Estrus; Female; Gonadotropins, Equine; Humans; In Vitro Techniques; Male; Ovariectomy; Ovary; Ovulation; Rats; Rats, Inbred Strains; Testosterone | 1991 |
Effects of dibutyryl cAMP, LHRH, and aromatase inhibitor on simultaneous outputs of prostaglandin F2 alpha, and 13,14-dihydro-15-keto-prostaglandin F2 alpha by term placental explants.
Topics: Androstenedione; Aromatase Inhibitors; Bucladesine; Chorionic Gonadotropin; Culture Techniques; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dinoprost; Female; Gonadotropin-Releasing Hormone; Humans; Kinetics; Lipoproteins, LDL; Placenta; Pregnancy; Prostaglandins F | 1982 |
Effects of dibutyryl adenosine 3',5'-monophosphate, luteinizing hormone-releasing hormone, and aromatase inhibitor on simultaneous outputs of progesterone, 17 beta-estradiol, and human chorionic gonadotropin by term placental explants.
Topics: Androstenedione; Bucladesine; Cholesterol; Cholesterol, LDL; Chorionic Gonadotropin; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Synergism; Estradiol; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Humans; Lipoproteins, LDL; Placenta; Pregnancy; Progesterone | 1982 |